Valuation: Abbott Laboratories

Market Cap 174B 152B 141B 130B 245B 16,720B 248B 1,683B 658B 8,194B 652B 638B 28,292B P/E 2026 *
27.8x
P/E 2027 * 21.7x
Enterprise Value 197B 173B 160B 147B 278B 18,971B 281B 1,909B 747B 9,298B 739B 724B 32,103B EV / Sales 2026 *
3.92x
EV / Sales 2027 * 3.46x
Free-Float
86.73%
Yield 2026 *
2.6%
Yield 2027 * 2.73%
1 day+0.82%
1 week+12.04%
Current month+9.84%
1 month+12.74%
3 months+7.50%
6 months-17.44%
Current year-20.45%
1 week 94.99
Extreme 94.99
102.46
1 month 87.64
Extreme 87.64
102.46
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

363 0.0000%
6/30/26 Tax

EXECUTIVE VICE PRESIDENT

-269 0.0000%
6/30/26 Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%+12.04%-19.89%-12.79% 174B
-0.18%+2.63%-9.89%-6.96% 105B
+1.23%+3.37%+4.64%+60.13% 58.97B
-1.59%-1.13%+39.37%+57.81% 52.24B
-0.45%-0.39%-14.90%-44.90% 42.39B
-1.23%-0.28% - - 33.05B
-2.04%+3.28%-11.75%-41.19% 28.84B
-0.21%+1.18%+65.93%-3.41% 25.38B
-0.33%-0.43%-5.87%-9.31% 20.64B
-1.85%+0.89%-6.76%-1.26% 20.28B
Average -0.57%+2.20%+4.54%-0.21% 56.08B
Weighted average by Cap. -0.10%+4.79%-3.26%+0.41%

Financials

2026 *2027 *
Net sales 50.31B 44.1B 40.86B 37.61B 70.92B 4,845B 71.77B 488B 191B 2,375B 189B 185B 8,199B 54.7B 47.94B 44.42B 40.89B 77.1B 5,268B 78.03B 530B 207B 2,582B 205B 201B 8,914B
Net income 6.44B 5.65B 5.23B 4.81B 9.08B 620B 9.19B 62.44B 24.43B 304B 24.18B 23.66B 1,050B 8.07B 7.08B 6.56B 6.03B 11.38B 778B 11.52B 78.25B 30.62B 381B 30.31B 29.65B 1,316B
Net Debt 23.38B 20.49B 18.99B 17.48B 32.96B 2,252B 33.36B 227B 88.69B 1,104B 87.77B 85.88B 3,810B 15.74B 13.8B 12.79B 11.77B 22.19B 1,516B 22.46B 153B 59.72B 743B 59.1B 57.83B 2,566B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-07-22 $100.20 +0.53% 520,955
26-07-21 $99.67 -1.96% 11,656,451
26-07-20 $101.66 +0.97% 14,390,641
26-07-17 $100.68 +1.87% 19,913,777
26-07-16 $98.83 +10.71% 32,755,801
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
99.67USD
Average target price
118.54USD
Spread / Average Target
+18.93%

Quarterly revenue - Rate of surprise